Ghana Approves First Malaria Vaccine, Raising Hopes for Dramatic Reduction in Disease

Oxford University's promising malaria vaccine received its first regulatory approval in Ghana, a landmark step forward in combating a disease that kills hundreds of thousands of children in Africa each year.
The vaccine has demonstrated an effectiveness rate of 80% in testing and has a deal in place to manufacture up to 200 million doses annually.
Never before has a major new vaccine been approved in a developing country before rich nations.
Researchers hope the ongoing final-stage trials will pave the way for approvals in additional African countries and save thousands of lives.